Screening of human gene promoter activities using transfected-cell arrays.

[1]  A. Godzik,et al.  A Novel PAAD-containing Protein That Modulates NF-κB Induction by Cytokines Tumor Necrosis Factor-α and Interleukin-1β* , 2002, The Journal of Biological Chemistry.

[2]  M. Janitz,et al.  High-throughput gene silencing using cell arrays , 2004, Oncogene.

[3]  H. Lehrach,et al.  Cell array-based intracellular localization screening reveals novel functional features of human chromosome 21 proteins , 2006, BMC Genomics.

[4]  D. Sabatini,et al.  Microarrays of cells expressing defined cDNAs , 2001, Nature.

[5]  A. Godzik,et al.  A novel PAAD-containing protein that modulates NF-kappa B induction by cytokines tumor necrosis factor-alpha and interleukin-1beta. , 2002, The Journal of biological chemistry.

[6]  J. Fernández-Luna,et al.  NLRP2, an Inhibitor of the NF-κB Pathway, Is Transcriptionally Activated by NF-κB and Exhibits a Nonfunctional Allelic Variant1 , 2007, The Journal of Immunology.

[7]  H. Lehrach,et al.  An efficient and economic enhancer mix for PCR. , 2006, Biochemical and biophysical research communications.

[8]  J. Kere,et al.  Expression Analysis of the NLRP Gene Family Suggests a Role in Human Preimplantation Development , 2008, PloS one.

[9]  S. Akira,et al.  Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins1 , 2002, The Journal of Immunology.

[10]  Martin Vingron,et al.  T-STAG: resource and web-interface for tissue-specific transcripts and genes , 2005, Nucleic Acids Res..

[11]  Thomas Lengauer,et al.  CpG Island Mapping by Epigenome Prediction , 2007, PLoS Comput. Biol..

[12]  R. Myers,et al.  Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome. , 2005, Genome research.

[13]  T. Wang,et al.  Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity , 2004, Journal of endotoxin research.

[14]  Martin Vingron,et al.  Genome-scale design of PCR primers and long oligomers for DNA microarrays. , 2003, Nucleic acids research.

[15]  E. Fikrig,et al.  Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice , 2002, Nature Medicine.

[16]  Yong Wang,et al.  An evaluation of new criteria for CpG islands in the human genome as gene markers , 2004, Bioinform..

[17]  M. Bucan,et al.  Promoter features related to tissue specificity as measured by Shannon entropy , 2005, Genome Biology.

[18]  Yoann Roupioz,et al.  Quantitative analysis of highly parallel transfection in cell microarrays. , 2004, Nucleic acids research.

[19]  T. Oelgeschläger,et al.  Core promoter-selective RNA polymerase II transcription. , 2006, Biochemical Society symposium.

[20]  Alexander E. Kel,et al.  MATCHTM: a tool for searching transcription factor binding sites in DNA sequences , 2003, Nucleic Acids Res..

[21]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[22]  Ferenc Müller,et al.  New Problems in RNA Polymerase II Transcription Initiation: Matching the Diversity of Core Promoters with a Variety of Promoter Recognition Factors* , 2007, Journal of Biological Chemistry.

[23]  H. Lehrach,et al.  High-throughput mammalian two-hybrid screening for protein-protein interactions using transfected cell arrays , 2008, BMC Genomics.

[24]  J. T. Kadonaga,et al.  The RNA polymerase II core promoter - the gateway to transcription. , 2008, Current opinion in cell biology.

[25]  J. Fernández-Luna,et al.  NLRP2, an inhibitor of the NF-kappaB pathway, is transcriptionally activated by NF-kappaB and exhibits a nonfunctional allelic variant. , 2007, Journal of immunology.

[26]  Daiya Takai,et al.  Comprehensive analysis of CpG islands in human chromosomes 21 and 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Marcel H. Schulz,et al.  A Global View of Gene Activity and Alternative Splicing by Deep Sequencing of the Human Transcriptome , 2008, Science.

[28]  Paul B. Fisher,et al.  mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[29]  José Martínez-Aroza,et al.  CpGcluster: a distance-based algorithm for CpG-island detection , 2006, BMC Bioinformatics.

[30]  E. Wingender,et al.  MATCH: A tool for searching transcription factor binding sites in DNA sequences. , 2003, Nucleic acids research.

[31]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.

[32]  S. Schreiber,et al.  Expression signatures, barriers and beyond: the role of oxidative stress in murine colitis and human inflammatory bowel disease revisited , 2008, European journal of gastroenterology & hepatology.

[33]  P. Bucher Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. , 1990, Journal of molecular biology.

[34]  M. Janitz,et al.  Functional genomics using high-throughput RNA interference. , 2005, Drug discovery today.

[35]  Boris Lenhard,et al.  Mammalian RNA polymerase II core promoters: insights from genome-wide studies , 2007, Nature Reviews Genetics.

[36]  M. Brčić,et al.  The response of HEK293 cells transfected with bovine TLR2 to established pathogen-associated molecular patterns and to bacteria causing mastitis in cattle. , 2008, Veterinary immunology and immunopathology.

[37]  F. Re,et al.  Importance of extra- and intracellular domains of TLR1 and TLR2 in NFκB signaling , 2003, The Journal of cell biology.

[38]  S. Pestka,et al.  Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene , 2004, Oncogene.

[39]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.